Company: DAWN
Filing Date: 2025-11-13
Form Type: SC TO-C
Source: 0001104659-25-110833
Chunk: 3

Company: Day One Biopharmaceuticals, Inc.
Filing Date: 2025-11-13
Form: SC TO-C
Chunk 3
---
 it more difficult to conduct business
as usual or maintain relationships with customers, employees or suppliers; the risk that Day One will not be able to retain the employees
of Mersana following the closing of the transaction given the at-will nature of their employment; risks associated with acquisitions,
such as the risk that the businesses will not be integrated successfully, that such integration may be more difficult, time-consuming
or costly than expected or that the expected benefits of the transaction will not occur; risks associated with developing product candidates;
risks and uncertainties related to unforeseen delays that may impact the timing of clinical trials and reporting data; risks related to
future opportunities and plans for Mersana and its product candidates, including uncertainty of the expected financial performance of
Mersana and its product candidates and the possibility that the milestone payments related to the contingent value right will never be
achieved and that no milestone payment may be made; the possibility that if Day One does not achieve the perceived benefits of the proposed
transaction as rapidly or to the extent anticipated by financial analysts or investors, the market price of Day One’s shares could
decline; as well as other risks related to Day One’s and Mersana’s businesses detailed from time-to-time under the
caption “Risk Factors” and elsewhere in Day One’s and Mersana’s respective SEC filings and reports, including
their respective Annual Reports on Form 10-K for the year ended December 31, 2024 and subsequent quarterly and current reports
filed with the SEC. Day One undertakes no duty or obligation to update any forward-looking statements contained in this communication
as a result of new information, future events or changes in their expectations, except as required by law.

Item 12. Exhibits